Anti-Human SIRPA Therapeutic Antibody scFv Fragment (AM4-1)

Recombinant monoclonal antibody specifically binds to SIRPĪ± and can block engagement of SIRPa by CD47The antibody can be potentially used in treating hematological cancer.
Supplier Creative Biolabs
Product # TAB-454CT-S(P)
Pricing Inquiry
Host Human
Target SIRPA
Species Reactivity Human
Type Human antibody
Applications Used for immunoassay techniques such as: Enzyme-linked Immunosorbent Assay
Feedback